14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of JANX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Janux Therapeutics, Inc.
(Updated on Apr 24, 2024)

Buy or Hold candidate since Feb 20, 2024 Gain 384.04% PDF

The Janux Therapeutics, Inc. stock price fell by -3.15% on the last day (Wednesday, 24th Apr 2024) from $49.78 to $48.21. During the last trading day the stock fluctuated 7.53% from a day low at $46.55 to a day high of $50.06. The price has been going up and down for this period, and there has been a 8.05% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -132 thousand shares and in total, 575 thousand shares were bought and sold for approximately $27.70 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 383.12% during the next 3 months and, with a 90% probability hold a price between $211.21 and $283.36 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

JANX Signals & Forecast

The Janux Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $48.99. On a fall, the stock will find some support from the long-term average at approximately $41.96. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -8.43%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Janux Therapeutics, Inc. stock

Janux Therapeutics, Inc. finds support from accumulated volume at $47.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.51 between high and low, or 7.53%. For the last week, the stock has had daily average volatility of 6.60%.

Our recommended stop-loss: $45.55 (-5.52%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (JANX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Janux Therapeutics, Inc. to open at $48.27, and during the day (based on 14 day Average True Range), to move between $44.43 and $51.99, which gives a possible trading interval of +/-$3.78 (+/-7.83%) up or down from last closing price. If Janux Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 15.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $48.38 (0.35%) than the support at $47.67 (1.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Janux Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Janux Therapeutics, Inc. stock to perform well in the short-term.

Current score: 2.975 Buy Candidate Unchanged

Predicted Opening Price for Janux Therapeutics, Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$48.27 ( 0.128%) $48.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for JANX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 51.78 7.40 %
R2 50.44 4.62 %
R1 49.61 2.91 %
Current price: 48.21
Support S1 46.93 -2.65 %
S2 46.11 -4.37 %
S3 44.77 -7.14 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 50.00 3.71 %
R2 49.75 3.19 %
R1 48.38 0.353 %
Current price 48.21
Support S1 47.67 -1.12%
S2 46.60 -3.35%
S3 44.62 -7.45%

FAQ

What is the symbol for Janux Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Janux Therapeutics, Inc. is JANX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Janux Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Janux Therapeutics, Inc. stock to perform well in the short-term.

How to buy Janux Therapeutics, Inc. Stock?
Janux Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Janux Therapeutics, Inc. Stock.

What's the current price of Janux Therapeutics, Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Janux Therapeutics, Inc. (JANX) share was $48.21.

What is the 52-week high and low for Janux Therapeutics, Inc. Stock?
The 52-week high for Janux Therapeutics, Inc. Stock is $58.39 and the 52-week low is $5.65.

What is the market capitalization of Janux Therapeutics, Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Janux Therapeutics, Inc. is 2.572B.

When is the next earnings date for Janux Therapeutics, Inc.?
The upcoming earnings date for Janux Therapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Janux Therapeutics, Inc.

Janux Therapeutics. Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a ... JANX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT